Immunotherapy in Sarcoma | Sarcoma Talk #10 with Javier Martin Broto
In this Sarcoma Talk on OncoDaily, Dr. Javier Martin Broto, Sarcoma Medical Oncologist at the University Hospital Fundación Jiménez Díaz (Madrid), joins host Shushan Hovsepyan. Dr. Martin Broto explores the evolving role of immunotherapy in sarcomas, highlighting the challenges of biomarker identification and the potential of tertiary lymphoid structures (TLS). He shares insights from clinical trials, including promising results of chemoimmunotherapy in leiomyosarcoma and plans for a randomized phase 2 study.
Dr. Javier Martin Broto is one of the most respected figures in sarcoma research and clinical trials. He is a medical oncologist at the Fundación Jimenez Diaz University Hospital in Madrid, where he leads the Advanced Therapies and Biomarkers in Sarcoma (ATBSarc) lab. He is also a founding member and vice-chairman of the Spanish Group for Research on Sarcomas (GEIS).
Shushan Hovsepyan is the Editor in Chief of the OncoDaily Medical Journal, a pediatric oncologist and an adjunct assistant professor at the Yerevan State Medical University. Currently, she is the Editor-in-Chief of OncoDaily Medical Journal.
00:00 Introduction
01:17 Current Immunotherapy Approaches for Sarcoma
04:11 Immunotherapy in Sarcoma: Key Challenges & Markers
08:31 Leiomyosarcoma Trial: Chemo & Nivolumab Insights
14:18 Combating Immune Resistance in Sarcoma
16:38 Inspiration and Focus: A Journey into Oncology
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023